RxDoctor Payments Data

Lisa Yablon

Neurology · New York, NYNPI 1821251489

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,550 of the $14,913 with a category attached, or 70.7%. AbbVie accounts for 84.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $8,011 and has fallen 93.2% since, to $547 in 2022.

$14,913in general payments, 2019–2025

Across 354 payments — averaging $42.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13K
  • Teva Pharmaceuticals USA, Inc.$411
  • Upsher-smith Laboratories LLC$392
  • Biohaven Pharmaceuticals, Inc.$311
  • Supernus Pharmaceuticals, Inc.$288
  • Assertio Therapeutics, Inc.$229
  • plus $660 from 10 others

What the payments were for

  • Speaking & faculty fees$10,55071%
  • Food & beverage$4,31129%
  • Education$520%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,913 in reported general payments places this provider in the 80th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Other neurology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →